PubMed HealthSearch

PubMed · 7968452

Interleaved echo planar flow quantitation.

Abstract

A method is presented for rapid blood flow quantitation. It combines multiple shot echo planar imaging principles with phase contrast velocity encoding gradients. Preliminary validation experiments performed on a flow phantom indicate a good correlation with actual flow values. Measurements of pulsatile flow in the ascending and descending aorta, acquired in just 4 s, with a temporal resolution of 50 ms, are demonstrated.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G C McKinnon, J F Debatin, D R Wetter, G K von Schulthess. 1994. Interleaved echo planar flow quantitation.. https://doi.org/10.1002/mrm.1910320218

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-invasive blood pressure measurements and aortic blood flow velocity in neonates.

We studied the systolic blood pressure difference between the upper and the lower extremities in healthy newborn infants and the effect of the isthmic narrowing of the aorta on the possible difference. The blood pressure was measured with an oscillometric blood pressure device from every extremity of 36 healthy infants aged 2-5 days. A Doppler echocardiography was performed for each infant to measure the aortic blood flow velocity in the ascending aorta and in the aortic arch above and below the isthmic narrowing. The mean blood pressure readings (S.D.) were the following: the right arm 76.8 (7.3)/48.1 (6.9), the left arm 77.5 (7.4)/51.6 (7.0), the right thigh 77.7 (7.1)/40.7 (5.8), the left thigh 76.8 (6.4)/39.6 (5.8), the right calf 75.5 (7.1)/46.6 (5.7) and the left calf 77.1 (8.6)/48.7 (6.7). The aortic blood flow was faster below the isthmic narrowing of the aorta (1.15 +/- 0.19 m/s) than in the ascending aorta (0.93 +/- 0.12 m/s) or in the aortic arch above the isthmus (0.99 +/- 0.15 m/s). The calculated pressure gradient between the ascending aorta and aorta below the isthmus was 2.0 +/- 1.8 mmHg and between opposite sides of the isthmus 1.5 +/- 1.2 mmHg. Unlike in childhood and adolescence, the systolic blood pressure in the lower extremities of healthy newborn infants is not higher than in the upper extremities. The physiological narrowing of the aortic arch does not explain this phenomenon. If blood pressure measurements are performed on a neonate to rule out aortic coarctation, the readings obtained must be interpreted in respect to normal values in newborns.

Aorta

Cardiac risk stratification for high-risk vascular surgery.

BACKGROUND: The best strategy for cardiac risk assessment before high-risk vascular surgery remains controversial. A cardiac risk stratification protocol was evaluated in patients undergoing high-risk vascular surgery. Our investigation paralleled the elaboration of the American College of Cardiology/ American Heart Association (ACC/AHA) Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery and is highly comparable to the proposed guidelines. METHODS AND RESULTS: A cardiac risk stratification protocol was evaluated prospectively in 203 patients scheduled for aortic surgery. Key points of the study were cardiac mortality/morbidity and cost-effectiveness. Patients were stratified into low (n = 101), intermediate (n = 79), and high (n = 23) cardiac risk after clinical predictors. After stratification, the degree of estimated functional capacity assessed by treadmill exercise and daily living activities and expressed by metabolic equivalents (METs) was critical for further cardiac evaluation. In intermediate-risk patients with an estimated functional capacity < 5 METs and in all high-risk patients, noninvasive cardiac testing and/or subsequent medical care were performed. Noninvasive testing was considered necessary in 41 patients, coronary angiography in 7, and myocardial revascularization in 1. Overall hospital mortality was 3.5%. Cardiac mortality and morbidity were 1% and 12.4%, respectively. CONCLUSIONS: Cardiac risk stratification for high-risk vascular surgery patients, according to a protocol similar to the ACC/AHA Guidelines for Cardiovascular Evaluation for Noncardiac Surgery, demonstrated excellent clinical outcome. This approach appears to be a safe and economical strategy for preoperative cardiac evaluation.

Aorta

3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.

Oxidation of LDL may be of pivotal importance in atherogenesis, but the mechanisms that promote oxidation in vivo remain poorly understood. We have explored the possibility that one pathway involves myeloperoxidase, a heme protein secreted by phagocytes. Myeloperoxidase is the only human enzyme known to generate hypochlorous acid (HOCl), a potent oxidizing agent, at physiological halide concentrations. LDL exposed to the complete myeloperoxidase-H2O2-Cl- system underwent chlorination of its protein tyrosyl residues. Treatment of LDL with reagent HOCl resulted in 3-chlorotyrosine formation, implicating HOCl as an intermediate in the enzymatic reaction pathway. In contrast, 3-chlorotyrosine was undetectable in LDL oxidized by hydroxyl radical, copper, iron, hemin, glucose, peroxynitrite, horseradish peroxidase, lactoperoxidase, or lipoxygenase. These results indicate that 3-chlorotyrosine is a specific marker for LDL oxidation by myeloperoxidase. To address the role of myeloperoxidase in promoting LDL oxidation in vivo, we used stable isotope dilution gas chromatography-mass spectrometry to quantify 3-chlorotyrosine in human aortic tissue and in LDL isolated from atherosclerotic lesions. The level of 3-chlorotyrosine in atherosclerotic tissue obtained during vascular surgery was sixfold higher than that of normal aortic intima. Moreover, the level of 3-chlorotyrosine was 30-fold higher in LDL isolated from atherosclerotic intima compared with circulating LDL. The detection of 3-chlorotyrosine in human atherosclerotic lesions indicates that halogenation reactions catalyzed by the myeloperoxidase system of phagocytes constitute one pathway for protein oxidation in vivo. These findings raise the possibility that the myeloperoxidase-H2O2-Cl- system plays a critical role in converting LDL into an atherogenic form.

Aorta